ERIBULIN for Angiosarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 26 adverse event reports in the FDA FAERS database where ERIBULIN was used for Angiosarcoma.
Most Reported Side Effects for ERIBULIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 675 | 13.4% | 112 | 289 |
| Malignant neoplasm progression | 594 | 11.8% | 228 | 158 |
| Myelosuppression | 520 | 10.3% | 2 | 380 |
| Febrile neutropenia | 448 | 8.9% | 65 | 378 |
| Neutrophil count decreased | 294 | 5.8% | 14 | 159 |
| Neuropathy peripheral | 290 | 5.7% | 44 | 124 |
| White blood cell count decreased | 289 | 5.7% | 10 | 146 |
| Pyrexia | 275 | 5.4% | 66 | 218 |
| Disease progression | 211 | 4.2% | 67 | 53 |
| Fatigue | 209 | 4.1% | 72 | 111 |
| Anaemia | 188 | 3.7% | 29 | 108 |
| Leukopenia | 185 | 3.7% | 51 | 103 |
| Nausea | 183 | 3.6% | 48 | 102 |
| Interstitial lung disease | 171 | 3.4% | 30 | 91 |
| Thrombocytopenia | 168 | 3.3% | 55 | 87 |
Other Indications for ERIBULIN
Breast cancer (1,736)
Breast cancer metastatic (1,152)
Product used for unknown indication (355)
Breast cancer recurrent (346)
Triple negative breast cancer (171)
Invasive ductal breast carcinoma (127)
Her2 positive breast cancer (108)
Soft tissue sarcoma (66)
Breast cancer stage iv (58)
Chemotherapy (52)
Other Drugs Used for Angiosarcoma
PAZOPANIB (164)
PACLITAXEL (148)
DOXORUBICIN (126)
DOCETAXEL (94)
GEMCITABINE (67)
SIROLIMUS (59)
IFOSFAMIDE (53)
NIVOLUMAB (46)
PEMBROLIZUMAB (37)
BEVACIZUMAB (36)